Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006

被引:47
作者
Otten, Johannes D. M. [1 ,4 ]
Broeders, Mireille J. M. [1 ,2 ,4 ]
Fracheboud, Jacques [3 ,4 ]
Otto, Suzie J. [3 ,4 ]
de Koning, Harry J. [3 ,4 ]
Verbeek, Andre L. M. [1 ,4 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6500 HB Nijmegen, Netherlands
[2] Natl Expert & Training Ctr Breast Canc Screening, Nijmegen, Netherlands
[3] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands
[4] Univ Med Ctr Rotterdam, Erasmus MC, Natl Evaluat Team Breast Canc Screening Netherlan, Rotterdam, Netherlands
关键词
breast cancer screening; trends; mortality; incidence;
D O I
10.1002/ijc.23736
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to assess changes in the trends in breast cancer mortality and incidence from 1975 to 2006 among Dutch women, in relation to the implementation of the national breast cancer screening programme. Screening started in 1989 for women aged 50-69 and was extended to women aged 70-75 years in 1998 (attendance rate approximately >80%). A joinpoint Poisson regression analysis was used to identify significant changes in rates over time. Breast cancer mortality rates increased until 1994 (age group 35-84), but thereafter showed a marked decline of 2.3-2.8% per annum for the age groups 55-64 and 65-74 years, respectively. For the age group of 75-84 years, a decrease started in the year 2001. In women aged 45-54, an early decline in breast cancer mortality rates was noted (1971-1980), which is ongoing from 1992. Far all ages, breast cancer incidence rates showed an increase between 1989 and 1993, mainly caused by the age group 50-69, and thereafter, a moderate increase caused by age group 70-74 years. This increase can partly be explained by the introduction of screening. The results indicate an impressive decrease in breast cancer mortality in the age group invited for breast cancer screening, starting to show quite soon after implementation. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:1929 / 1934
页数:6
相关论文
共 25 条
[1]  
ABE O, 1992, LANCET, V339, P71
[2]  
Berry Donald A, 2006, J Natl Cancer Inst Monogr, P30, DOI 10.1093/jncimonographs/lgj006
[3]   EXTRA INCIDENCE CAUSED BY MAMMOGRAPHIC SCREENING [J].
BOER, R ;
WARMERDAM, P ;
DEKONING, H ;
VANOORTMARSSEN, G .
LANCET, 1994, 343 (8903) :979-979
[4]   Breast cancer incidence and mortality trends in 16 European countries [J].
Botha, JL ;
Bray, F ;
Sankila, R ;
Parkin, DM .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (12) :1718-1729
[5]  
Clarke M, 1998, LANCET, V351, P1451
[6]  
Coebergh J W, 1990, Ned Tijdschr Geneeskd, V134, P760
[7]   HRT use in 2001 and 2004 in The Netherlands - A world of difference [J].
de Jong-van den Berg, Lolkje T. W. ;
Faber, Adrianne ;
van den Berg, Paul B. .
MATURITAS, 2006, 54 (02) :193-197
[8]   Overdiagnosis and overtreatment of breast cancer - Microsimulation modelling estimates based on observed screen and clinical data [J].
de Koning, HJ ;
Draisma, G ;
Fracheboud, J ;
de Bruijn, A .
BREAST CANCER RESEARCH, 2006, 8 (01)
[9]   Mammographic screening: evidence from randomised controlled trials [J].
de Koning, HJ .
ANNALS OF ONCOLOGY, 2003, 14 (08) :1185-1189
[10]  
*EARL BREAST CANC, 1992, LANCET, V339, P1